Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.96 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.96 |
| ▸ | LMNA | P02545 | 4/20 | 0.96 |
| ▸ | TP53 | P04637 | 3/20 | 0.96 |
| ▸ | HTT | P42858 | 3/20 | 0.96 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.96 |
| ▸ | HPGD | P15428 | 3/20 | 0.96 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.96 |
| ▸ | POLB | P06746 | 1/20 | 0.83 |
| ▸ | NPC1 | O15118 | 3/20 | 0.71 |
| ▸ | RAB9A | P51151 | 2/20 | 0.71 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.71 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.71 |
| ▸ | RELA | Q04206 | 1/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.71 |
| ▸ | PNLIP | P16233 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | CA1 | P00915 | 1/20 | 0.65 |
| ▸ | CA9 | Q16790 | 1/20 | 0.65 |
| ▸ | FADS1 | O60427 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Salicylanilide SCHEMBL28262329 | 0.98 | MEN1 (1.00) | MEN1KMT2ALMNATP53HTT | |
| Salicylanilide SCHEMBL20165864 | 0.98 | MEN1 (1.00) | MEN1KMT2ALMNATP53HTT | |
| Salicylanilide SCHEMBL152221 | 0.98 | MEN1 (1.00) | MEN1KMT2ALMNATP53HTT | |
| Salicylanilide SCHEMBL14051034 | 0.98 | MEN1 (1.00) | MEN1KMT2ALMNATP53HTT | |
| Salicylanilide SCHEMBL28868416 | 0.96 | MEN1 (0.96) | MEN1KMT2ALMNATP53HTT | |
| Salicylanilide SCHEMBL28474195 | 0.96 | MEN1 (0.96) | MEN1KMT2ALMNATP53HTT | |
| Salicylanilide SCHEMBL11597375 | 0.96 | MEN1 (0.96) | MEN1KMT2ALMNATP53HTT | |
| Salicylanilide SCHEMBL2968865 | 0.96 | MEN1 (0.96) | MEN1KMT2ALMNATP53HTT | |
| Salicylanilide SCHEMBL9300362 | 0.96 | MEN1 (0.96) | MEN1KMT2ALMNATP53HTT | |
| Salicylanilide SCHEMBL5377091 | 0.96 | MEN1 (0.96) | MEN1KMT2ALMNATP53HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107915927-A | A kind of composition for the discharge duct being used to prepare in double profile tube drainaging system | 苏州水博士建材科技有限公司 | 2018-04-17 | — | — | CN | disclosed |
| US-20060276339-A1 | Methods and compositions for increasing the efficacy of biologically-active ingredients | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2006-12-07 | — | — | US | disclosed |
| WO-2006085859-A1 | BIOCIDAL COMPOSITIONS | STOCKEL RICHARD F (US) | 2006-08-17 | — | — | WO | disclosed |
| US-7074459-B2 | Method for preserving wood | BRIDGEWATER INTELLECTUAL PROPERTIES LLC | 2006-07-11 | — | — | US | disclosed |
| US-20050048005-A1 | Antimicrobial compositions for dental applications | BRIDGEWATER INTELLECTUAL PROPERTIES LLC | 2005-03-03 | — | — | US | disclosed |
| US-20040234496-A1 | Biocidal compositions | STOCKEL RICHARD F (US) | 2004-11-25 | — | — | US | disclosed |
| US-20040234492-A1 | contacting the wood with a wood preserving aqueous emulsion containing anionic and cationic biocides that form complexes; nontoxic, synergistic, free of heavy metals | BRIDGEWATER INTELLECTUAL PROPERTIES LLC | 2004-11-25 | — | — | US | disclosed |
| US-5041225-A | Hydrophilic semi-permeable PTFE membranes and their manufacture | NORMAN EDDIE (GB) | 1991-08-20 | — | — | US | disclosed |
| EP-0408378-A2 | Hydrophilic semi-permeable PTFE membranes and their manufacture | W.L. GORE & ASSOCIATES (UK) LTD (GB) | 1991-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060276339-A1 | Methods and compositions for increasing the efficacy of biologically-active ingredients | ENPP1, ENPP3, SMPD1 | MEN1 1618/4885KMT2A 2581/4885LMNA 3199/4885 |
| US-20050048005-A1 | Antimicrobial compositions for dental applications | TAS2R8, TAS2R41, CXCL8 | MEN1 2448/4885KMT2A 3458/4885LMNA 4087/4885 |
| US-20040234496-A1 | Biocidal compositions | MPO, MMP8, MMP9 | MEN1 667/4885KMT2A 3971/4885LMNA 3471/4885 |
| US-20040234492-A1 | contacting the wood with a wood preserving aqueous emulsion containing anionic and cationic biocides that form complexes; nontoxic, synergistic, free of heavy metals | MGAM, CMA1, MME | MEN1 322/4885KMT2A 3367/4885LMNA 339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.